Skip to main content

Digital Therapeutics Market Technology, Size, Growth and Research Report 2020

Digital Therapeutics Market Competitive Research Analysis By Product Type (Software, Devices And Others), Application (Cardiovascular Diseases, Obesity, Diabetes, Respiratory Diseases, Smoking Cessation, And Others), Sales Channel (B2B And B2C) And End Users – Global Forecast 2023
Digital therapeutics Market Overview
Digital therapeutics, generally known as programming for medications has been increasing a lot of consideration because of the quantity of advantages it offers to patients that use it. Consistent observing of patient’s fundamental details, capacity to guarantee adherence to prescriptions, brief updates are the absolute most significant advantages offered by digital therapeutics.
The development of the market is slung by expanding rates of interminable sicknesses, expanding accentuation on preventive human services, the need to control medicinal services uses, and included advantages offered by digital therapeutics. Ascend in number of investors that are putting resources into the market is another factor that is quickening its development.
The Global expansion in the web use and reliance over cell phones, digital therapeutics offers simple following and observing of patients and their fundamental details without mediation. This serves in a discrete and non-interventional way to convince people to receive more beneficial ways of life and improve physical prosperity.
Digital therapeutics Market Competitive Analysis:
The key players operating in the global digital therapeutics market include –
Proteus Digital Health Inc.
WellDoc Inc.
Omada Health Inc.
2Morrow Inc.
Propeller Health
Livongo Health
Twine Health Inc.
Noom Inc.
Canary Health Inc.
and Others.
The key players are trying to offer newer products with advanced facilities are driving growth of the global digital therapeutics market.
Digital therapeutics Market Segmentation:
The digital therapeutics market is segmented based on product type, application, sales channel, and region.
In terms of product type, the global digital therapeutics market is categorized into software and devices.
Based on the application, the market is segmented into cardiovascular diseases, diabetes, obesity, smoking cessation, respiratory diseases, and other.
Based on the sales channel, the market is segmented into B2B and B2C.
Table Of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Trends
4.5 Macroeconomic Indicators
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Value Chain Analysis
Chapter 6. Global Digital Therapeutics Market, By Product Type
6.1 Introduction
6.2 Software
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
6.3 Devices
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
Chapter 7. Global Digital Therapeutics Market, By Application
7.1 Introduction
7.2 Obesity
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
7.3 Cardiovascular Diseases
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
7.4 Diabetes
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
7.5 Smoking Cessation
Continued…
Digital therapeutics Market Regional Analysis:
Based on the region, the market is segmented into Europe, the Americas, Asia Pacific, and the Rest of the World (RoW). Of these, the Americas are estimated hold strong position in the digital therapeutics market owing to The North American district added to the biggest market offer attributable to innovatively propelled therapeutic foundation and effective execution of mobile wellbeing in their social insurance framework.
However, Asia Pacific is estimated to be fastest growth in the coming years for the digital therapeutics market. Developing nations like India, China and Brazil are additionally expected to prosper during the estimate time frame inferable from reception of improved human services foundation and therapeutic advancements to control the anticipation of incessant sicknesses.
About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future | +1 646 845 9312 | Email: sales@marketresearchfuture.com

Comments

Popular posts from this blog

Immunoassay Analyzers Market By Methods, Technologies, Clinical Review and Industry Outlook

  Immunoassay Analyzers Market  Research Report By Instruments (Immunofluorescence, Chemiluminescence, ELISA, Radioimmunoassay), Application (Infectious Diseases, Autoimmune Diseases, AIDS), End Users (Hospitals)- Global Forecast till 2023 Market Scenario Immunoassay analyzer is a device which measures the presence and concentration of proteins in analyte samples. These instruments are mostly used by pharmaceutical & biotechnological companies, laboratories, and research institutes. The global immunoassay analyzer market is driven by an increasing number of pharmaceutical and biotechnological companies, rising prevalence of different life-threatening diseases, and government’s initiatives for research & development activities. Furthermore, rapid development in diagnostic medical devices, increasing need for better drug treatment, and the increasing geriatric population had also fueled the market’s growth. On the other hand, high cost of instruments and poor reimburseme...

Laser Therapy Market Top Company Profiles, Latest Technology, Global Size, Industry Trends

  Laser Therapy Market  Research Report, By Type (Diode Lasers, Solid State Lasers, Gas Lasers, Dye Lasers, and others), By Application (Dermatology and Aesthetics, Surgery, Dental, Urology, Ophthalmology, and others) - Global Forecast from 2017 to 2023 Market Overview: Market Research Future (MRFR) anticipates strong CAGR of 9.2% in the global laser therapy market over the forecast period of 2017-2023. The expansion of the global laser therapy is the result of various market dynamics, out of which, the surging prevalence of diseases such as cataract and arthritis bears profound weightage. Laser therapy is the standard line of treatment in cases of cataract. Laser-based ophthalmology is highly preferred over other methods of treatment. YAG LASER, excimer LASER, femtosecond LASER, and others are the most commonly used lasers in ophthalmology. The widespread prevalence of cataract, as well as arthritis, promote the growth of the global laser therapy market. Expanding base of old...

Nonallergic Rhinitis Market Data, Technology Treatment and Diagnosis Management Overview

  Nonallergic Rhinitis Market  Share, Growth And Trends Analysis By Diagnosis (Physical Examination, Allergy Testing, And Imaging Test), By Treatment (Nasal Sprays, Nsaids), And By End User (Hospitals &, Clinics, Research Centers) - Global Forecast Till 2023 Market Highlights Nonallergic rhinitis, also known as vasomotor rhinitis is a medical condition that refers to a set of symptoms that resemble nasal allergies and hayfever (allergic rhinitis) occurring without a known cause. Some of the symptoms of non-allergic rhinitis include Postnasal drip, Runny nose, Sneezing, and Stuffy nose among others. Some patients with nonallergic rhinitis may even develop allergies and asthma eventually, hence treating the condition well in time becomes essential. Industry, Innovation & Related News November 08, 2018 – AstraZeneca Plc. (the UK), a multinational pharmaceutical and biopharmaceutical company announced the sale of its rights for asthma drug Alvesco (ciclesonide), nasal spra...